MedPath
HSA Approval

LIVTENCITY FILM-COATED TABLET 200MG

SIN17208P

LIVTENCITY FILM-COATED TABLET 200MG

LIVTENCITY FILM-COATED TABLET 200MG

March 18, 2025

TAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE. LTD.

Regulatory Information

TAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE. LTD.

Therapeutic

Prescription Only

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

J05AX10

Manufacturer Information

TAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE. LTD.

Catalent CTS, LLC

Active Ingredients

Maribavir

200mg

Maribavir

Documents

Package Inserts

Livtencity PI.pdf

Approved: March 18, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LIVTENCITY FILM-COATED TABLET 200MG - HSA Approval | MedPath